Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Thomas Stephen Basil
Director at Climb Bio. Filing since 12 Feb 2026.
CIK 0002027962
Company
Date
Role
Action
Shares
Amount
Of holding
CLYM
Climb Bio, Inc.
15 Sep 2026
Director
Sold on a plan
100,000
$1.37M
17.6%
CLYM
Climb Bio, Inc.
26 Feb 2026
Director
Sold on a plan
16,313
$114.29K
9.5%
CLYM
Climb Bio, Inc.
25 Feb 2026
Director
Sold on a plan
33,687
$235.96K
16.5%
CLYM
Climb Bio, Inc.
13 Feb 2026
Director
Sold on a plan
10,000
$58.14K
4.7%
CLYM
Climb Bio, Inc.
12 Feb 2026
Director
Sold on a plan
90,000
$470.99K
29.5%
5 decisions on file.
